These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30567154)

  • 1. Acute mountain sickness (AMS) in a Nepali pilgrim after rapid ascent to a sacred lake (4380 m) in the Himalayas.
    Thapa SS; Basnyat B
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High altitude illness in pilgrims after rapid ascent to 4380 M.
    Zafren K; Pun M; Regmi N; Bashyal G; Acharya B; Gautam S; Jamarkattel S; Lamichhane SR; Acharya S; Basnyat B
    Travel Med Infect Dis; 2017; 16():31-34. PubMed ID: 28285976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas.
    Basnyat B; Subedi D; Sleggs J; Lemaster J; Bhasyal G; Aryal B; Subedi N
    Wilderness Environ Med; 2000; 11(2):89-93. PubMed ID: 10921358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding of Altitude Illness and Use of Pharmacotherapy Among Trekkers and Porters in the Annapurna Region of Nepal.
    Havryliuk T; Acharya B; Caruso E; Cushing T
    High Alt Med Biol; 2015 Sep; 16(3):236-43. PubMed ID: 26244262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the workload of the two high altitude aid posts in the Nepal Himalayas.
    Basnyat B; Savard GK; Zafren K
    J Travel Med; 1999 Dec; 6(4):217-22. PubMed ID: 10575168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High altitude pilgrimage medicine.
    Basnyat B
    High Alt Med Biol; 2014 Dec; 15(4):434-9. PubMed ID: 25330393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric High Altitude Cerebral Edema in the Nepal Himalayas.
    Church BJ; Basnyat B; Mattingly B; Zafren K
    Wilderness Environ Med; 2019 Sep; 30(3):306-309. PubMed ID: 31301992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
    Vardy J; Vardy J; Judge K
    Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up.
    McDevitt M; McIntosh SE; Rodway G; Peelay J; Adams DL; Kayser B
    Wilderness Environ Med; 2014 Jun; 25(2):152-9. PubMed ID: 24864065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of patients with severe altitude illness in Nepal.
    Leshem E; Pandey P; Shlim DR; Hiramatsu K; Sidi Y; Schwartz E
    J Travel Med; 2008; 15(5):315-22. PubMed ID: 19006504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal.
    Newcomb L; Sherpa C; Nickol A; Windsor J
    Wilderness Environ Med; 2011 Sep; 22(3):197-201. PubMed ID: 21962045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m.
    Koehle MS; Wang P; Guenette JA; Rupert JL
    High Alt Med Biol; 2006; 7(4):281-9. PubMed ID: 17173513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mountaineering and altitude sickness].
    Maggiorini M
    Ther Umsch; 2001 Jun; 58(6):387-93. PubMed ID: 11441701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Acetaminophen or Ibuprofen Results in Equivalent Acute Mountain Sickness Incidence at High Altitude: A Prospective Randomized Trial.
    Kanaan NC; Peterson AL; Pun M; Holck PS; Starling J; Basyal B; Freeman TF; Gehner JR; Keyes L; Levin DR; O'Leary CJ; Stuart KE; Thapa GB; Tiwari A; Velgersdyk JL; Zafren K; Basnyat B
    Wilderness Environ Med; 2017 Jun; 28(2):72-78. PubMed ID: 28479001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Newly Constructed Motor Vehicle Road on Altitude Illness in the Nepal Himalayas.
    Reisman J; Deonarain D; Basnyat B
    Wilderness Environ Med; 2017 Dec; 28(4):332-338. PubMed ID: 28781177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
    Phillips L; Basnyat B; Chang Y; Swenson ER; Harris NS
    High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and Acute Mountain Sickness in Himalayan Trekkers in Nepal: An Observational Cohort Study.
    Duke CB; Sallade TD; Starling J; Pant S; Sheets A; McElwee MK; Young DS; Taylor RA; Keyes LE
    Wilderness Environ Med; 2020 Jun; 31(2):157-164. PubMed ID: 32205041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate Dexamethasone Use by a Trekker in Nepal: A Case Report.
    Haslam NR; Garth R; Kelly N
    Wilderness Environ Med; 2017 Dec; 28(4):318-321. PubMed ID: 28870508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
    BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory rate within the first hour of ascent predicts subsequent acute mountain sickness severity.
    Jafarian S; Gorouhi F; Ghergherechi M; Lotfi J
    Arch Iran Med; 2008 Mar; 11(2):152-6. PubMed ID: 18298291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.